BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 19209951)

  • 1. Tuberculosis drug resistance mutation database.
    Sandgren A; Strong M; Muthukrishnan P; Weiner BK; Church GM; Murray MB
    PLoS Med; 2009 Feb; 6(2):e2. PubMed ID: 19209951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
    Tungusova OS; Mar'iandyshev AO
    Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug resistance and fitness in Mycobacterium tuberculosis infection.
    Bottger EC; Pletschette M; Andersson D
    J Infect Dis; 2005 Mar; 191(5):823-4; author reply 824. PubMed ID: 15688309
    [No Abstract]   [Full Text] [Related]  

  • 4. Integration of published information into a resistance-associated mutation database for Mycobacterium tuberculosis.
    Salamon H; Yamaguchi KD; Cirillo DM; Miotto P; Schito M; Posey J; Starks AM; Niemann S; Alland D; Hanna D; Aviles E; Perkins MD; Dolinger DL
    J Infect Dis; 2015 Apr; 211 Suppl 2(Suppl 2):S50-7. PubMed ID: 25765106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of drug resistance in tuberculosis.
    Riska PF; Jacobs WR; Alland D
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S4-10. PubMed ID: 10688142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CASTB (the comprehensive analysis server for the Mycobacterium tuberculosis complex): A publicly accessible web server for epidemiological analyses, drug-resistance prediction and phylogenetic comparison of clinical isolates.
    Iwai H; Kato-Miyazawa M; Kirikae T; Miyoshi-Akiyama T
    Tuberculosis (Edinb); 2015 Dec; 95(6):843-844. PubMed ID: 26542225
    [No Abstract]   [Full Text] [Related]  

  • 7. Polyclonal tuberculosis and the emergence of drug resistance.
    Behr MA
    Am J Respir Crit Care Med; 2005 Sep; 172(5):521-2. PubMed ID: 16120715
    [No Abstract]   [Full Text] [Related]  

  • 8. Microbiology. TB--a new target, a new drug.
    Cole ST; Alzari PM
    Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
    [No Abstract]   [Full Text] [Related]  

  • 9. A First Insight into the
    Franco-Sotomayor G; Garzon-Chavez D; Leon-Benitez M; de Waard JH; Garcia-Bereguiain MA
    Microb Drug Resist; 2019 May; 25(4):524-527. PubMed ID: 30513056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.
    Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3672-3. PubMed ID: 14576145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shortening the treatment of tuberculosis.
    Mitchison DA
    Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to antimicrobial agents in Mycobacterium tuberculosis.
    Pfyffer GE
    Acta Cient Venez; 2001; 52 Suppl 1():36-9. PubMed ID: 11899703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting Activation of and Mechanism of Resistance to Compound IQG-607 in Mycobacterium tuberculosis.
    Abbadi BL; Villela AD; Rodrigues-Junior VS; Subtil FT; Dalberto PF; Pinheiro APS; Santos DS; Machado P; Basso LA; Bizarro CV
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
    Rodrigues Vde F; Telles MA; Ribeiro MO; Cafrune PI; Rossetti ML; Zaha A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):444-6. PubMed ID: 15616332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
    Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
    Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
    Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
    Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis. Few mutations divide some drug-resistant TB strains.
    Koenig R
    Science; 2007 Nov; 318(5852):901-2. PubMed ID: 17991835
    [No Abstract]   [Full Text] [Related]  

  • 18. Tuberculosis drug resistance: summary report for 2003.
    Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis drug resistance in Canakkale, Turkey.
    Gonlugur T; Basol G; Gonlugur U
    Cent Eur J Public Health; 2020 Sep; 28(3):245. PubMed ID: 32997482
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular-genetic method of identification of drug-resistant Mycobacterium tuberculosis].
    Dubileĭ SA; Ignatova AN; Shemiakin IG
    Mol Gen Mikrobiol Virusol; 2005; (1):3-7. PubMed ID: 15790026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.